FDA officials have set a review date of June 30, 2025, to review avutometinib in combination with defactinib to treat patients with recurrent low-grade serous ovarian cancer. The FDA has accepted ...

G.R. Fasteners constantly exceed customer expectations by having the capacity to provide same day delivery and unparalleled levels of customer service. It is the combination of increased capacity, ...